Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cohort profile: the Mexico City Prospective Study.
Tapia-Conyer R, Kuri-Morales P, Alegre-Díaz J, Whitlock G, Emberson J, Clark S, Peto R, Collins R. Tapia-Conyer R, et al. Int J Epidemiol. 2006 Apr;35(2):243-9. doi: 10.1093/ije/dyl042. Epub 2006 Mar 23. Int J Epidemiol. 2006. PMID: 16556648 Review. No abstract available.
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
Heart Protection Study Collaborative Group; Emberson JR, Ng LL, Armitage J, Bowman L, Parish S, Collins R. Heart Protection Study Collaborative Group, et al. Among authors: emberson jr. J Am Coll Cardiol. 2007 Jan 23;49(3):311-9. doi: 10.1016/j.jacc.2006.08.052. J Am Coll Cardiol. 2007. PMID: 17239712 Free article. Clinical Trial.
Analyses of cancer data from three ezetimibe trials.
Peto R, Emberson J, Landray M, Baigent C, Collins R, Clare R, Califf R. Peto R, et al. N Engl J Med. 2008 Sep 25;359(13):1357-66. doi: 10.1056/NEJMsa0806603. Epub 2008 Sep 2. N Engl J Med. 2008. PMID: 18765432 Free article.
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Antithrombotic Trialists' (ATT) Collaboration; Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Antithrombotic Trialists' (ATT) Collaboration, et al. Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1. Lancet. 2009. PMID: 19482214 Free PMC article.
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
Cholesterol Treatment Trialists’ (CTT) Collaboration; Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R. Cholesterol Treatment Trialists’ (CTT) Collaboration, et al. Lancet. 2010 Nov 13;376(9753):1670-81. doi: 10.1016/S0140-6736(10)61350-5. Epub 2010 Nov 8. Lancet. 2010. PMID: 21067804 Free PMC article.
213 results